Childhood cancer patients comprise a special and understudied population of cancer patients. Approximately 15,000 childhood cancer patients are diagnosed in the United States annually, compared with the 1.7 million new cancer cases diagnosed each year. Due to their rare nature, it has been challenging to collect substantial and vital information on a large scale to study and understand the needs for this unique population of cancer patients.
The Childhood Cancer Data Initiative (CCDI) symposium hosted by the National Cancer Institute (NCI) in July 2019 identified a critical need to collect, analyze, and share data to address the burden of cancer in children, adolescents and young adults. Currently, cancer registries in the United States hold structured information on every cancer case, including childhood cancers, within their respective catchment area. For childhood cancer patients and survivors, issues of late effects, recurrence, subsequent primary cancers, and follow-up are critically important to consider while addressing common instances of survivors moving to different states as these survivors mature and become adults. Using the data from registries as a base, an infrastructure that brings together key information on every childhood cancer patient is being constructed and will be maintained to support research on childhood cancer patients and survivors.
The National Childhood Cancer Registry (NCCR) is envisioned as a connected data infrastructure to enable sharing of childhood cancer data from multiple and heterogeneous data sources. Incorporating available data on genomic and tumor characterization, residential history, social determinants of health and measures of financial toxicity, longitudinal treatments including oral agents, and longitudinal outcomes data including recurrence and subsequent cancers can enhance the core infrastructure of registry data on pediatric patients. Because the basis for the NCCR is existing central cancer registries, personally identifiable information (PII) is reportable to the central registry to permit longitudinal linkage and reporting to central registries is HIPAA exempt. The NCCR will 1) support relevant research on childhood cancers; 2) provide a potential sampling frame for additional research; and 3) provide a population level set of data on all childhood cancer patients, including patients who do not participate in clinical trials.
To explore funded sites, click on the icon in the top left corner of the map, click on any pin on the map, or scroll down to view a funded initiatives table.
|Cancer Center||Address||National Childhood Cancer Registry|
|Abramson Cancer Center||3400 Spruce St., Philadelphia, PA 19104|
|Dana-Farber Cancer Institute/Harvard Cancer Center||450 Brookline Ave., Boston, MA 02215|
|Herbert Irving Comprehensive Cancer Center of Columbia University||1130 St Nicholas Ave., New York, NY 10032|
|Huntsman Cancer Institute||2000 Circle of Hope, Salt Lake City, UT 84112|
|The Ohio State University Comprehensive Cancer Center||650 Ackerman Road, Columbus, Ohio 43202|
|Roswell Park Comprehensive Cancer Center||Elm & Carlton Streets, Buffalo, NY 14263|
|UCSF Helen Diller Family Comprehensive Cancer Center||1450 3rd St., San Francisco, CA 94115|
|UK Markey Cancer Center||800 Rose St., Lexington, KY 40536|
|University of Michigan Rogel Cancer Center||1500 E. Medical Center Drive, Ann Arbor, MI 48109|
|University of Texas Health Science Center at San Antonio||7979 Wurzbach Road, San Antonio, TX 78229|